复星可以通过PDE4D/PKA/Drp1信号传递改善糖尿病脑病变
Yanjuan Cao1, Wen Sun1, Chang Liu1
1Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu Province 221004, China.
Brain research bulletin
|September 18, 2023
概括
复星可以通过抑制PDE4D,神经退行的一个关键因素,保护糖尿病脑病变. 这项研究表明,通过调节PDE4D/PKA通路,复星可以改善糖尿病小鼠的认知功能和线粒体健康.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病脑病变 (DE) 是一种导致认知能力下降的糖尿病并发症.
- 目前还没有有效的治疗方法可以阻止ED的进展.
- 二酶4D (PDE4D) 通过PKA信号传递与神经退行性疾病有关.
研究的目的:
- 研究PDE4D在糖尿病脑病变中的作用.
- 为了确定复星是否通过抑制PDE4D来保护DE.
- 为了阐明底层的PDE4D/PKA信号通路.
主要方法:
- 使用了db/db小鼠和HT22海马细胞.
- 使用的PDE4D晶状病毒 (过度表达/敲击) 和PKA抑制剂H89.
- 评估认知功能,神经毒性,cAMP,PKA和线粒体功能.
主要成果:
- 在db/db小鼠中,复星减弱了认知障碍,并恢复了线粒体功能.
- 在体外,抑制PDE4D改善了高葡萄糖诱导的神经毒性.
- 过度表达PDE4D会削弱复星的保护作用;PKA抑制会否定它们.
结论:
- ресвератрол显示出对糖尿病脑病变的神经保护作用.
- PDE4D/PKA通路对于复星的治疗作用至关重要.
- 通过通过PDE4D抑制调节线粒体功能,白醇可以改善认知功能.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
610
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
221
相关概念视频
01:20Pathophysiology of Diabetes
980
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
980
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K